Raydiant Oximetry is a venture-backed, clinical-stage company dedicated to improving outcomes for mothers and babies during childbirth. The company has developed an innovative technology, LUMERAH™, a low-cost, non-invasive sensor that monitors fetal oxygenation during labor, with the aim to better identify fetal distress and reduce the rate of medically unnecessary C-sections. LUMERAH™ is an investigational medical device that is not currently approved for commercial sale.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/18/21 | $2,000,000 | Series A-2 |
Avestria Ventures FemHealth Ventures Rhia Ventures SteelSky Ventures | undisclosed |
